Baixar PDF

Outros usuários também visualizaram estes artigos

DOENÇA RESIDUAL MÍNIMA EM CRIANÇAS COM LEUCEMIA LINFOBLÁSTICA AGUDA COMO MARCADOR PROGNÓSTICO KHR Costa; VU Lavorato; HC Teixeira; IMQ Magalhães; R Camargo; ACS Dias; RM Pontes; JCM Córdoba; V Tizian; FM Furtado;
Hematol Transfus Cell Ther. 2022;44 Supl 2:S341
ASSESSMENT OF MINIMAL RESIDUAL DISEASE BY NEXT-GENERATION FLOW CYTOMETRY AFTER INITIAL INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA IN A PUBLIC PEDIATRIC HOSPITAL MCC Magalhães; RM Pontes; FM Furtado; BC Guido; ACMD Santos-Junior; RA Toscano; IMQ Magalhães; R Camargo; JCM Códoba;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S198-9
BLINATUMOMAB: ANALYSIS OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN PEDIATRIC PATIENTS DIAGNOSED WITH RELAPSED/REFRACTORY PH-NEGATIVE B-ALL TF Nunes; RM Pontes; ACS Dias; JCM Córdoba; IMQ Magalhães; R Camargo; FM Furtado;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S661